Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
188 hedge funds and large institutions have $1.85B invested in Medicines Co in 2018 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 78 increasing their positions, 46 reducing their positions, and 38 closing their positions.
70% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 46
11% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 38
2% more funds holding
Funds holding: 184 → 188 (+4)
21% less call options, than puts
Call options by funds: $43.2M | Put options by funds: $54.4M
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
35% less capital invested
Capital invested by funds: $2.83B → $1.85B (-$981M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$50.9M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
+$50M |
| 3 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$33M |
| 4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$20M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$19.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$87.6M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$76.6M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
-$27.2M |
| 4 |
LPC
Lion Point Capital
New York
|
-$21.8M |
| 5 |
O
OppenheimerFunds
New York
|
-$21.2M |
MDCO Hedge Fund Activity: Q4 2018 in Review
188 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2018, worth a combined $1.85B — down 35% from $2.83B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new MDCO positions and 38 closed out — a net gain of 4 holders — while 78 added to existing stakes and 46 trimmed.
The largest buyer was HealthCor Management, adding an estimated $50.9M. The largest seller was PointState Capital, exiting entirely with an estimated $87.6M sold.
- 188 institutional investors held Medicines Co (MDCO) as of Q4 2018, up from 184 in Q3 2018.
- Funds reported $1.85B of Medicines Co stock for Q4 2018, down 35% quarter-over-quarter.
- 42 funds opened new Medicines Co positions in Q4 2018 and 38 closed out, a net change of +4 holders.
- The largest Medicines Co buyer in Q4 2018 was HealthCor Management, an estimated $50.9M added.
- The largest Medicines Co seller in Q4 2018 was PointState Capital, an estimated $87.6M sold.
Based on aggregated 13F filings for Q4 2018.